Clinical Research Directory

Browse clinical research sites, groups, and studies.

1 clinical study listed.

Healthy volunteers

Filters:

Epithelial Ovarian Cancer, Fallopian Tube or Peritoneum

Tundra lists 1 Epithelial Ovarian Cancer, Fallopian Tube or Peritoneum clinical trial. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.

This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.

NOT YET RECRUITING

NCT06838429

PARPi and Ovarian Cancer Survival

With the widespread use of PARP inhibitors (PARPi) as maintenance therapy in ovarian cancer, there is still a lack of real-world data from large samples regarding their impact on survival outcomes in advanced and recurrent ovarian cancer. This study aims to conduct a pragmatic cohort study to evaluate the impact of first-line and second-line maintenance treatment with PARPi on survival rates in patients with advanced and recurrent ovarian cancer. The genetic status, different PARPi drugs, and the use of anti-angiogenic inhibitor maintenance therapy or not is used as confounding factors.

Gender: FEMALE

Ages: 18 Years - 80 Years

Updated: 2025-02-20

Epithelial Ovarian Cancer, Fallopian Tube or Peritoneum

PARP Inhibitor